Chemist, Inventor, Entrepreneur and now a Fellow
Dr Graham Ruecroft is a co-founder and former director and CTO of Prosonix (Oxford) where he developed and co-invented a number of novel ultrasound assisted manufacturing methods for superior particles designed for respiratory medicines. He left Prosonix upon a completion of a substantial Series B fund-raising to facilitate new respiratory drug development. Prior to his work with Prosonix and its precursor, Accentus PLC, Graham held senior research and development positions in Ferring Research, Enzymatix, Chiroscience, ChiroTech, Ascot Fine Chemicals, Dow Chemical and Ultrafine.
His background includes medicinal, synthetic, chiral, process and solid-state chemistries. Graham also has considerable skills in the use of ultrasound in chemical and biochemical processing. He is currently developing a new “green” business whereby growth platform chemicals such as lactic acid can be economically produced from renewable no-food waste streams such as lignocellulose via industrial ultrasound assisted bioprocessing. Graham will be playing a key role in growing IKE’s Bioscience and Biotechnology Networking Forum.